Nuvation Bio Inc. Basic Shares Outstanding (Weighted Average)
Nuvation Bio Inc. (NUVB) reported Basic Shares Outstanding (Weighted Average) of 348.77 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 348.77K shares, a 2.35% increase year-over-year.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 347.33K shares, a 2.58% increase year-over-year.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 344.37K shares, a 2.06% increase year-over-year.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 342.39K shares, a 25.16% increase year-over-year.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 341.54K shares, a 27.07% increase from fiscal 2024.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 268.77K shares, a 22.79% increase from fiscal 2023.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 218.88K shares, a 1.00% increase from fiscal 2022.
- Nuvation Bio Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 216.72K shares, a 9.52% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 348.77K shares 10-Q · filed 2026-08-06 | 348.06K shares 10-Q · filed 2026-08-06 | 346.82K shares derived: average of 3 quarters · filed 2026-08-06 | 345.72K shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 347.33K shares 10-Q · filed 2026-05-04 | 345.85K shares derived: average of 2 quarters · filed 2026-05-04 | 344.70K shares derived: average of 3 quarters · filed 2026-05-04 | 343.71K shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 344.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 343.38K shares derived: average of 2 quarters · filed 2026-03-02 | 342.50K shares derived: average of 3 quarters · filed 2026-08-06 | 341.54K shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 342.39K shares 10-Q · filed 2025-11-03 | 341.57K shares derived: average of 2 quarters · filed 2026-08-06 | 340.60K shares 10-Q · filed 2025-11-03 | 339.80K shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 340.75K shares 10-Q · filed 2026-08-06 | 339.69K shares 10-Q · filed 2026-08-06 | 338.93K shares derived: average of 3 quarters · filed 2026-08-06 | 322.59K shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 338.61K shares 10-Q · filed 2026-05-04 | 338.02K shares derived: average of 2 quarters · filed 2026-05-04 | 316.54K shares derived: average of 3 quarters · filed 2026-05-04 | 298.59K shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 337.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 305.50K shares derived: average of 2 quarters · filed 2026-03-02 | 285.25K shares derived: average of 3 quarters · filed 2026-03-02 | 268.77K shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 273.56K shares 10-Q · filed 2025-11-03 | 259.15K shares derived: average of 2 quarters · filed 2025-11-03 | 245.88K shares 10-Q · filed 2025-11-03 | 239.09K shares derived: average of 4 quarters · filed 2025-11-03 |
| 2024-06-30 | 244.74K shares 10-Q · filed 2025-08-07 | 231.89K shares 10-Q · filed 2025-08-07 | 227.59K shares derived: average of 3 quarters · filed 2025-08-07 | 225.43K shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 219.05K shares 10-Q · filed 2025-05-07 | 219.02K shares derived: average of 2 quarters · filed 2025-05-07 | 218.99K shares derived: average of 3 quarters · filed 2025-05-07 | 218.96K shares derived: average of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 218.99K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 218.96K shares derived: average of 2 quarters · filed 2025-03-06 | 218.93K shares derived: average of 3 quarters · filed 2025-03-06 | 218.88K shares 10-K · filed 2025-03-06 |
| 2023-09-30 | 218.94K shares 10-Q · filed 2024-11-06 | 218.89K shares derived: average of 2 quarters · filed 2024-11-06 | 218.84K shares 10-Q · filed 2024-11-06 | 218.76K shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 218.85K shares 10-Q · filed 2024-08-05 | 218.79K shares 10-Q · filed 2024-08-05 | 218.70K shares derived: average of 3 quarters · filed 2024-08-05 | 218.60K shares derived: average of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | 218.74K shares 10-Q · filed 2024-05-14 | 218.63K shares derived: average of 2 quarters · filed 2024-05-14 | 218.52K shares derived: average of 3 quarters · filed 2024-05-14 | 218.04K shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 218.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 218.41K shares derived: average of 2 quarters · filed 2024-02-29 | 217.81K shares derived: average of 3 quarters · filed 2024-02-29 | 216.72K shares 10-K · filed 2024-02-29 |
| 2022-09-30 | 218.30K shares 10-Q · filed 2023-11-02 | 217.45K shares derived: average of 2 quarters · filed 2023-11-02 | 216.12K shares 10-Q · filed 2023-11-02 | 214.67K shares derived: average of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | 216.60K shares 10-Q · filed 2023-08-03 | 215.02K shares 10-Q · filed 2023-08-03 | 213.46K shares derived: average of 3 quarters · filed 2023-08-03 | 211.87K shares derived: average of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 213.41K shares 10-Q · filed 2023-05-04 | 211.88K shares derived: average of 2 quarters · filed 2023-05-04 | 210.29K shares derived: average of 3 quarters · filed 2023-05-04 | 208.72K shares derived: average of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | 210.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 208.73K shares derived: average of 2 quarters · filed 2023-03-15 | 207.16K shares derived: average of 3 quarters · filed 2023-03-15 | 197.89K shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 207.10K shares 10-Q · filed 2022-11-03 | 205.56K shares derived: average of 2 quarters · filed 2022-11-03 | 193.73K shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 204.02K shares 10-Q · filed 2022-08-04 | 186.93K shares 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |